Legal Opinion
Sti Pharma, LLC v. Azar
District Court, District of Columbia
Decided March 23, 2020No. Civil Action No. 2018-1231Published
1Opinion of the Court
UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA STI PHARMA, LLC, Plaintiff, v. Civil Action No. 18-1231 (RDM) ALEX M. AZAR, II, et al., Defendants. MEMORANDUM OPINION When Congress added outpatient prescription drug coverage to the Medicaid program in 1990, it conditioned payment for prescription drugs on each manufacturer’s agreement to participate in the Medicaid Drug Rebate Program (“MDRP”). Under the terms of the MDRP, the percentage of the cost of the drug used to calculate the rebate that drug manufacturers must pay to participating states is determined, in part, based on…
2Cases cited37 opinions
- Chevron U. S. A. Inc. v. Natural Resources Defense Council, Inc.Supreme Court of the United States · 1984
- United States v. Mead Corp.Supreme Court of the United States · 2001
- Russello v. United StatesSupreme Court of the United States · 1983
- Richards v. United StatesSupreme Court of the United States · 1962
- Johnson v. United StatesSupreme Court of the United States · 2010
32 more not listed; retrieve them via the Exa API.